Ticker Details
Foghorn Therapeutics Inc.
IPO Date:	October 23, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$281.17M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.35 | 3.99%
Avg Daily Range (30 D):	$0.15 | 2.91%
Avg Daily Range (90 D):	$0.16 | 2.99%

Institutional Daily Volume
Avg Daily Volume:	.12M
Avg Daily Volume (30 D):	.13M
Avg Daily Volume (90 D):	.13M

Trade Size
Avg Trade Size (Sh.):	87
Avg Trade Size (Sh.) (30 D):	54
Avg Trade Size (Sh.) (90 D):	64

Institutional Trades
Total Institutional Trades:	85
Avg Institutional Trade:	$1.51M
Avg Institutional Trade (30 D):	$.98M
Avg Institutional Trade (90 D):	$.92M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.55M
Avg Closing Trade (30 D):	$.98M
Avg Closing Trade (90 D):	$.98M
Avg Closing Volume:	218.99K

News

Apr 9, 2026 @ 11:00 AM Foghorn Therapeutics to Present New Preclinical Da... Source: Na

Jan 14, 2026 @ 3:52 PM Precision Killers: Why Big Pharma is Betting Billi... Source: Prnewswire

Jan 10, 2026 @ 3:20 AM Foghorn Therapeutics Highlights January Equity Fin... Source: Na

Nov 17, 2025 @ 11:00 AM 4DMT Appoints Kristian Humer as Chief Financial Of... Source: 4D Molecular Therapeutics

Aug 27, 2025 @ 11:00 AM Foghorn Therapeutics to Participate in Three Upcom... Source: Karin Hellsvik

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.18	$-.34	$-1.18
Diluted EPS	$-1.18	$-.34	$-1.18
Revenue	$30.91M	$9.25M	$30.91M
Gross Profit
Net Income / Loss	$-74.28M	$-21.66M	$-74.28M
Operating Income / Loss	$-86.39M	$-23.88M	$-86.39M
Cost of Revenue
Net Cash Flow	$26.96M	$-8.46M	$26.96M
PE Ratio